A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A recent study highlights the effectiveness of Pain Coping Skills Training (PCST) in reducing chronic pain among dialysis patients. The study, involving 643 participants, shows how non-opioid ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...